Newsom and California are frequently the target of Trump’s ire. Some of his most memorable criticisms of the state have been over how it manages its wildlands in the face of wildfire risk. In his ...
By Daniella Parra Lisata Therapeutics said results from Cohort A of its Phase 2 ASCEND trial showed complete responses in 6.2% of certepetide-treated patients, compared to 0% in the placebo group. The ...